Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Aurkbem1/Cya
Common Name:
Aurkb-KO
Product ID:
S-KO-15932
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Aurkb-KO
Strain ID
KOCMP-20877-Aurkb-B6J-VA
Gene Name
Aurkb
Product ID
S-KO-15932
Gene Alias
AIM-1; AIRK2; Aik2; Aim1; Ark2; AurB; IPL1; STK-1; Stk12; Stk5
Background
C57BL/6JCya
NCBI ID
20877
Modification
Conventional knockout
Chromosome
11
Phenotype
MGI:107168
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Aurkbem1/Cya mice (Catalog S-KO-15932) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000021277
NCBI RefSeq
NM_011496.2
Target Region
Exon 2~6
Size of Effective Region
~1095 bp
Detailed Document
Click here to download >>
Overview of Gene Research
Aurkb, also known as Aurora kinase B, is a component of the chromosomal passenger protein complex. It plays a critical role in mitosis, regulating chromosome segregation, cell cycle checkpoint, and DNA damage response (DDR) [3]. It is also involved in normal physiological processes. In the context of cancer, it has emerged as an important carcinogenic factor [6].

Aurkb is significantly overexpressed in multiple cancers, such as hepatocellular carcinoma (HCC), bladder cancer, gastric cancer, and intrahepatic cholangiocarcinoma (ICC) [1,2,4,5]. In HCC, down-regulation of Aurkb inhibits cell proliferation, migration, invasion, induces apoptosis, and causes cell cycle arrest, and also inhibits lung metastasis. It interacts with DHX9 and promotes HCC progression through the PI3K/AKT/mTOR pathway [1]. In bladder cancer, knockdown of Aurkb suppresses cell proliferation, migration, invasion, and cell cycle progression, and induces senescence, and these effects can be rescued by MAD2L2 overexpression as Aurkb activates MAD2L2 to down-regulate the p53 DDR pathway [2]. In gastric cancer, silencing Aurkb inhibits cell proliferation, arrests the cell cycle in G2/M phase, and inhibits invasion and migration, potentially through inhibiting VEGFA/Akt/mTOR and Wnt/β-catenin/Myc pathways [4,7]. In ICC, Aurkb promotes cell proliferation, induces epithelial-mesenchymal transition (EMT), migration, and invasion, and in vivo promotes tumor growth and metastasis, regulating EMT-related genes via the PI3K/AKT signaling axis [5].

In conclusion, Aurkb is essential for mitosis and DDR. Its overexpression in various cancers promotes cancer progression, including cell proliferation, migration, invasion, and metastasis. Functional studies, especially those using loss-of-function approaches, have revealed its role in cancer-related biological processes, highlighting Aurkb as a potential therapeutic target in multiple cancer types [1,2,4,5,6,7].

References:

1. Zhu, Guoqing, Luo, Laihui, He, Yongzhu, Hu, Zhigao, Shan, Renfeng. 2024. AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway. In Molecular carcinogenesis, 63, 1814-1826. doi:10.1002/mc.23775. https://pubmed.ncbi.nlm.nih.gov/38874176/

2. Li, Linzhi, Jiang, Pengcheng, Hu, Weimin, Ning, Jinzhuo, Cheng, Fan. 2024. AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2. In Journal of translational medicine, 22, 295. doi:10.1186/s12967-024-05099-6. https://pubmed.ncbi.nlm.nih.gov/38515112/

3. Marima, Rahaba, Hull, Rodney, Penny, Clement, Dlamini, Zodwa. 2021. Mitotic syndicates Aurora Kinase B (AURKB) and mitotic arrest deficient 2 like 2 (MAD2L2) in cohorts of DNA damage response (DDR) and tumorigenesis. In Mutation research. Reviews in mutation research, 787, 108376. doi:10.1016/j.mrrev.2021.108376. https://pubmed.ncbi.nlm.nih.gov/34083040/

4. Nie, Min, Wang, Yadong, Yu, Zenong, Liu, Ming, Zhao, Quan. 2020. AURKB promotes gastric cancer progression via activation of CCND1 expression. In Aging, 12, 1304-1321. doi:10.18632/aging.102684. https://pubmed.ncbi.nlm.nih.gov/31982864/

5. Ma, Peng, Hao, Ying, Wang, Wei, Yu, Kai-Huan, Wang, Wei-Xing. 2023. AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progression. In Discover oncology, 14, 102. doi:10.1007/s12672-023-00707-1. https://pubmed.ncbi.nlm.nih.gov/37318676/

6. Wan, Bangbei, Huang, Yuan, Liu, Bo, Lu, Likui, Lv, Cai. 2019. AURKB: a promising biomarker in clear cell renal cell carcinoma. In PeerJ, 7, e7718. doi:10.7717/peerj.7718. https://pubmed.ncbi.nlm.nih.gov/31576249/

7. Wang, Zhen, Yu, Zhu, Wang, Gong-He, Chen, Jun-Qiang, Tian, Lei. 2020. AURKB Promotes the Metastasis of Gastric Cancer, Possibly by Inducing EMT. In Cancer management and research, 12, 6947-6958. doi:10.2147/CMAR.S254250. https://pubmed.ncbi.nlm.nih.gov/32801915/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest